Test Price
2,000 AED✅ Home Collection Available
FISH‑NTRK1/2/3 Gene Fusion Panel Test in UAE | 2000 AED | 2026 DHA Guidelines
تحليل لوحة جينات NTRK1/2/3 بالتهجين الموضعي المتألق في الإمارات | 2000 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved through ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139). Strict adherence to Federal Decree‑Law No. 41 of 2024 (Art. 87) and UAE CDS Law protections for minors.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة وفقًا لمعايير الآيزو، مع استشارة طبية هاتفية بعد الفحص.
Test Overview
The FISH‑NTRK1/2/3 Gene Fusion Panel precisely identifies NTRK gene rearrangements in paraffin‑embedded tumor tissue, guiding oncologists towards life‑changing targeted therapies with TRK inhibitors. This test delivers definitive diagnostic clarity for solid tumors where fusion status determines eligibility for histology‑agnostic treatment.
تحدد لوحة التهجين الموضعي المتألق طفرات اندماج جينات NTRK1/2/3 في أنسجة الورم المثبتة بالفورمالين، مما يوجه الأطباء نحو العلاجات الموجهة بمثبطات TRK.
| Feature | Our Test (FISH Panel) | Closest Alternative (NGS RNA‑Seq) |
|---|---|---|
| Precision | Direct visualisation of gene fusions in tissue architecture | High sensitivity but may miss low‑level fusions in heterogeneous samples |
| Method | Fluorescence In‑Situ Hybridisation (FISH) | Next‑Generation Sequencing of RNA |
| Turnaround Time | 4 Working Days | 7–14 Working Days |
| Tissue Requirement | Standard FFPE block/slides | Requires sufficient RNA quality; FFPE may degrade |
| UAE Regulatory Recognition | DHA/MOHAP accredited methodology | May require additional validation |
Physician Insight & Safety Protocol
“As an oncologist, I view NTRK fusion testing as a transformative step – a positive result can open the door to tumour‑agnostic therapies with remarkable response rates. However, fusion status must always be interpreted alongside full histopathological and clinical context; a negative result does not rule out other actionable drivers.”
— Dr. Prabhakar Reddy, DHA: 61713011
IMPORTANT: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Not validated for liquid biopsy (blood) samples – only FFPE tissue blocks/slides accepted.
- Unsuitable for germline (hereditary) NTRK mutation screening; this test detects somatic fusions in tumour tissue.
- Poorly fixed, necrotic, or decalcified tissue may cause inconclusive results – repeat biopsy may be required.
- Emergency: If following biopsy you experience severe pain, bleeding, fever, or signs of infection, seek immediate medical attention.
- Test results are not for stand‑alone diagnosis; always correlate with clinical and radiological findings.
Patient FAQ & Clinical Guidance
1. What exactly does the FISH‑NTRK gene fusion panel detect, and why is it critical for my cancer treatment?
This panel detects NTRK1, NTRK2, and NTRK3 gene rearrangements in your tumour tissue, a key biomarker that qualifies you for highly effective, tumour‑agnostic TRK inhibitor therapies.
تكشف هذه اللوحة عن اندماجات جينات NTRK1/2/3 في نسيج الورم، وهي علامة حيوية تؤهلك لعلاجات مثبطة TRK فائقة الفعالية بغض النظر عن نوع السرطان.
2. How should I prepare for the sample collection, and is home collection available?
No patient preparation is needed; our VIP mobile phlebotomy team will coordinate with your physician to collect the FFPE tissue block or slides, ensuring cold‑chain transport.
لا حاجة لتحضير المريض؛ سينسق فريق سحب الدم المتنقل لدينا مع طبيبك لجمع كتلة الأنسجة المثبتة بالفورمالين أو الشرائح، مع ضمان النقل بسلسلة تبريد.
3. What do the results mean, and what happens if an NTRK fusion is found?
A positive fusion result indicates eligibility for FDA‑approved NTRK‑targeted drugs like larotrectinib or entrectinib; your oncologist will then design a personalised treatment plan.
تعني نتيجة الاندماج الإيجابية الأهلية لتلقي أدوية معتمدة موجهة ضد NTRK مثل لاروتريكتينيب أو إنتريكتينيب؛ وسيضع طبيب الأورام بعدها خطة علاجية مخصصة.
UAE Regulatory & Compliance
This is performed under facility license 9834453 in strict accordance with Federal Decree‑Law No. 41 of 2024 (Medical Liability, Art. 87), UAE CDS Law provisions for minors (Federal Law No. 3 of 2016), and UAE PDPL (Federal Decree‑Law No. 45 of 2021). All data handling follows ISO 9001:2015 standards (Cert: INT/EGQ/2509DA/3139). Mandatory Genomics Clinical Information Requisition Form (Form 20) ensures informed consent and traceability.
For insurance verification & appointments, message us on WhatsApp: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians